Interdisciplinary collaboration
Access to the resources of Stanford University -- including the Schools of Engineering, Law, Business, Humanities & Sciences and Education
The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies
Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.
The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.
Inter-disciplinary teams of collaborative investigators partner to foster discovery, application and translation of scientific knowledge.
Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.
Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.
Internal and external sources of support for both established cancer research programs and promising new ideas.
The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.
Education and professional development designed to train the next generation of cancer researchers and physicians.
In addition to providing grants and other support to cancer researchers at institutions around the country, the National Cancer Institute employs scientists who conduct basic, clinical, and population-based research, including the study of rare cancers and the translation of laboratory findings to the clinic.
Physicians, researchers and other pacesetters describe some of the most promising pursuits in the medical field. In cancer, for instance: ‘Let’s kill the first cell, not the last cell.’…
New technology combines radiotherapy with real-time detection of cancer cells to target moving tumors or multiple metastases. Stanford Medicine is the first to research the technology in the clinic.